Products for Research Use Only

DRAK1 Peptide

CAT: 0223-2147PSize: 0.05 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0223-2147PSize:0.05 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
NCBI Gene ID
9263
Swiss Prot
Q9UEE5
Accession Number
Q9UEE5
Type
Peptides
Concentration
200 ug/mL
Buffer
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Shipping Conditions
Blue Ice
Storage Conditions
Store DRAK1 peptide at -20˚ C, stable for one year.
Applications Notes
DRAK1 peptide is used for blocking the activity of DRAK1 antibody.
NCBI Official Name
Serine/threonine kinase 17a
NCBI Organism
Homo sapiens
Background Reference 01
Sanjo H, Kawai T, Akira S. DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis. J Biol Chem 1998;273:29066-71.
Background Reference 02
Wesche H, Korherr C, Kracht M, Falk W, Resch K, Martin MU. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases) . J Biol Chem 1997;272:7727-31
Background Reference 03
Hofmeister R, Wiegmann K, Korherr C, Bernardo K, Kronke M, Falk W. Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein. J Biol Chem 1997;272:27730-6 (RD1299)
Other Product Names
DRAK1, DRAK1, DAP kinase-related apoptosis-inducing protein kinase 1
Tested Applications
Blocking
Species
Human
Protein ID
14423930
Physical Properties
Liquid

Popular Products